Pregna has recently announced the launch of its cryotherapy device CryoPop. The product was developed by Jhpiego with an objective of making treatment of cervical pre-cancerous lesions accessible to all. Pregna is the exclusive global commercialising partner for the device. “Cervical cancer is one of the most common and fatal forms of cancer in women worldwide, with about 85% of these deaths occurring in low and…
Every Thursday we send out a curated newsletter on “all things femtech and women’s health innovation”. This is the latest edition. If you’re interested in subscribing, you can do so at the bottom of this page. You’ve found some of our exclusive Inner Circle Content. This article is only available for our Inner Circle Members. To read on: Sign in to your…
Runway Growth Capital, a provider of growth loans to both venture and non-venture backed companies seeking an alternative to raising equity, announced today the closing of a senior secured term loan of $50 million to Gynesonics, a healthcare company focused on advancing women’s health by developing minimally invasive, incision-free, uterus-preserving, transcervical technologies for diagnostic and therapeutic applications. Gynesonics has developed and has received FDA clearance for…
Advantia Health today announced that veteran healthcare executive Vincent Bradley has joined the company as Chief Executive Officer. Advantia Health’s Co-Founder, Sean Glass, will continue in his role on the company’s board of directors. “As I decided that the time was right to recruit my successor into Advantia, I was looking to find an experienced healthcare CEO aligned with our mission of transforming…
Lina Behrens is the Managing Director of Flying Health, the leading ecosystem for Next Generation Healthcare and spends her days guiding industry leaders and digital health entrepreneurs as they explore and create tomorrow’s healthcare together. Beyond her daily work at Flying Health, Lina is a passionate advocate for female leadership and female entrepreneurship. She is a Vice President of the German Startup…
BioAesthetics Corporation today announced that it has doubled its initial Series A funding goal of $2.5 million, closed on Dec. 30, 2020, at $5 million to commercialize its NACgraft biologic matrix— a regenerative nipple graft for breast cancer survivors. BioAesthetics’ Series A was co-led by FemHealth Ventures and personally by BioAesthetics’ Director Sandra Coufal, MD, of Sibling Capital Ventures. BioAesthetics’ inaugural product, the NACgraft — for patients…
Healthcare inequities in the United States based on race, ethnicity and many other factors are making minorities more prone to not only receive inadequate care, but ultimately it could lead to death. Dr. Maria Hernandez, President and COO of Impact4Health, explains how inadequate training and poor engagement with Black and Brown communities can prove fatal for hospitals—and how this trend could be…
Echo Health Ventures, a strategic collaboration of Cambia Health Solutions and Mosaic Health Solutions to invest in innovative health care companies, today announced the formation of the Echo Innovation Alliance, a powerful strategic investing engine that extends Echo’s proven investment model. Echo and USAble Corporation will collaborate through the newly formed Alliance to invest in transformative companies and drive broader market impact.…
